RVTY — Revvity Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Revvity, fiscal year end - December 29th, USD millions except per share, conversion factor applied.

	2021 January 3rd	R2022 January 2nd	2023 December 31st	2023 January 1st	2024 December 29th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,783	3,828	2,751	3,312	2,755
Cost of Revenue
Gross Profit	2,110	2,434	1,540	1,990	1,538
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,804	2,569	2,450	2,569	2,408
Operating Profit	979	1,258	301	743	347
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	906	1,204	183	652	316
Provision for Income Taxes
Net Income After Taxes	728	889	180	513	283
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	728	943	693	569	270
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	728	943	693	569	270
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.75	8.14	2.23	4.31	2.85
Dividends per Share